We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Global Coagulometers Market to Be Driven by Rising Prevalence of Blood Disorders

By LabMedica International staff writers
Posted on 13 Jan 2022

The global coagulometers market is being driven by a rise in the incidence and prevalence of blood disorders such as hemophilia that is fueling the demand for more diagnostic tools.

These are the latest findings of Transparency Market Research (Albany NY, USA), a market intelligence provider.


Illustration
Illustration

Coagulation is a process wherein certain proteins and blood cells together create a gel-like clot to stop bleeding from a damaged or leaking blood vessel. Coagulometer is a device that is used to evaluate the efficiency of blood factors to form a clot. Coagulometers are widely used across the globe to diagnose hemophilia and other genetic hematological diseases. They are also used to monitor the progression of treatment with anti-coagulants in affected patients. These devices detect the time taken for coagulation in an ambient environment. Before the introduction of semi-automated and automated coagulation analyzers, these tests were performed manually. They involved high cost, skilled labor, and high probability of errors.

There has been rise in the incidence and prevalence of blood disorders such as hemophilia over the last few years. This high prevalence of blood disorders is estimated to drive the demand for more diagnostic tools, which in turn, is likely to propel the growth of the global coagulometers market. Moreover, the rising consumption of anti-coagulant drugs such as aspirin and heparin that necessitates the use of coagulometers to monitor the treatment progress in those patients is also fueling market growth. However, the high cost of these devices is diverting potential users towards manual coagulation testing, which is expected to restrain the growth of the global coagulometers market.

Based on technology, the global coagulometers market is dominated by the photo-optical detection and electrochemical detection segments which hold the highest market share as most automated coagulometers work on the principle of photo-optical or electrochemical detection. Based on channel type, the multichannel coagulometers segment holds the largest share in the global coagulometers market as multichannel coagulometers are widely used in diagnostic laboratories and hospitals. Based on end-user, the hospitals & diagnostic laboratories segment is expected to account for a major share of the global coagulometers market.

Geographically, North America is expected to hold a major share of the global coagulometers market, owing to high adoption of technology and high expenditure on health care by public and private sectors in the region. Europe is anticipated to account for a significant share of the global coagulometers market due to the high prevalence of blood disorders in the region. Local governing bodies in Asia Pacific are investing in the development of health care facilities and academic research institutes in the region, which is projected to propel the market for coagulometers in the region.

Related Links:
Transparency Market Research 


Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
One Step HbA1c Measuring System
GREENCARE A1c
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
New
Gold Member
TORCH Panel Rapid Test
Rapid TORCH Panel Test

Latest Industry News

Siemens to Close Fast Track Diagnostics Business

Beckman Coulter and Fujirebio Expand Partnership on Neurodegenerative Disease Diagnostics

Sysmex and Hitachi Collaborate on Development of New Genetic Testing Systems